Sudden cardiac death laboratory findings

Jump to navigation Jump to search

Sudden cardiac death Microchapters

Home

Patient Information

Sudden Cardiac versus Non-Cardiac Death

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Definitions and Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Urgent Treatment

Post Arrest Care and Prevention

Ethical Issues

Sudden cardiac death laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sudden cardiac death laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sudden cardiac death laboratory findings

CDC on Sudden cardiac death laboratory findings

Sudden cardiac death laboratory findings in the news

Blogs on Sudden cardiac death laboratory findings

Directions to Hospitals Treating Sudden cardiac death

Risk calculators and risk factors for Sudden cardiac death laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD[3]

Overview

Brain natriuretic peptide (BNP) or N-terminal pro-b-type-natriuretic peptide may have roles in the risk determination of patients for ventricular arrhythmia and sudden cardiac death.


Laboratory Findings


References

  1. Scott, Paul A.; Barry, James; Roberts, Paul R.; Morgan, John M. (2009). "Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis". European Journal of Heart Failure. 11 (10): 958–966. doi:10.1093/eurjhf/hfp123. ISSN 1388-9842.
  2. Patton KK, Sotoodehnia N, DeFilippi C, Siscovick DS, Gottdiener JS, Kronmal RA (2011). "N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study". Heart Rhythm. 8 (2): 228–33. doi:10.1016/j.hrthm.2010.10.038. PMC 3826546. PMID 21044699.
  3. Everett BM, Moorthy MV, Tikkanen JT, Cook NR, Albert CM (2020). "Markers of Myocardial Stress, Myocardial Injury, and Subclinical Inflammation and the Risk of Sudden Death". Circulation. 142 (12): 1148–1158. doi:10.1161/CIRCULATIONAHA.120.046947. PMC 7995996 Check |pmc= value (help). PMID 32700639 Check |pmid= value (help).
  4. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B; et al. (2002). "B-type natriuretic peptide predicts sudden death in patients with chronic heart failure". Circulation. 105 (20): 2392–7. doi:10.1161/01.cir.0000016642.15031.34. PMID 12021226.
  5. Scott PA, Barry J, Roberts PR, Morgan JM (2009). "Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis". Eur J Heart Fail. 11 (10): 958–66. doi:10.1093/eurjhf/hfp123. PMID 19789399.
  6. Ahmad T, Fiuzat M, Neely B, Neely ML, Pencina MJ, Kraus WE; et al. (2014). "Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure". JACC Heart Fail. 2 (3): 260–8. doi:10.1016/j.jchf.2013.12.004. PMC 4224312. PMID 24952693.

Template:WH Template:WS